Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-20

Clinical Trial Update: Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis [NA]

View source ↗

Summary

Clinical trial update on the effectiveness of the selective serotonin reuptake inhibitor citalopram (Cipralex) for prurigo nodularis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cipralex (citalopram)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Prurigo Nodularis | NA | Status: UNKNOWN